Yale Jen

Stock Analyst at Laidlaw & Co.

(0.05)
# 4,274
Out of 4,884 analysts
15
Total ratings
14.29%
Success rate
-44.95%
Average return
Main Sectors:

Stocks Rated by Yale Jen

Senti Biosciences
Jun 6, 2025
Initiates: Buy
Price Target: $5
Current: $2.20
Upside: +127.27%
iCAD, Inc.
Apr 17, 2025
Downgrades: Hold
Price Target: n/a
Current: $3.76
Upside: -
Soleno Therapeutics
Mar 27, 2025
Maintains: Buy
Price Target: $75$105
Current: $86.65
Upside: +21.18%
Nuvectis Pharma
Mar 17, 2025
Initiates: Buy
Price Target: $19
Current: $7.54
Upside: +151.99%
Lifeward
Feb 10, 2025
Initiates: Buy
Price Target: $10
Current: $0.67
Upside: +1,392.54%
ABIVAX Société Anonyme
Jul 29, 2024
Initiates: Buy
Price Target: $48
Current: $7.96
Upside: +503.02%
MEI Pharma
Jul 23, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.68
Upside: -
BiomX
May 28, 2024
Initiates: Buy
Price Target: $25
Current: $0.44
Upside: +5,581.82%
IN8bio
Mar 18, 2024
Initiates: Buy
Price Target: $225
Current: $2.18
Upside: +10,221.10%
Cingulate
Dec 22, 2023
Downgrades: Hold
Price Target: n/a
Current: $4.28
Upside: -
Initiates: Buy
Price Target: $10
Current: $0.62
Upside: +1,524.43%
Downgrades: Hold
Price Target: n/a
Current: $5.00
Upside: -
Initiates: Buy
Price Target: $240
Current: $2.44
Upside: +9,736.07%